iSpecimen Inc.
ISPC
$0.42
-$0.06-13.11%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -67.73% | -43.77% | -13.05% | -6.42% | 0.74% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -67.73% | -43.77% | -13.05% | -6.42% | 0.74% |
| Cost of Revenue | -51.34% | -24.11% | 6.14% | 10.01% | 12.56% |
| Gross Profit | -85.50% | -63.36% | -32.56% | -21.92% | -9.56% |
| SG&A Expenses | -8.29% | -13.99% | -10.15% | 3.74% | -11.22% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -23.16% | -18.50% | -7.04% | 4.37% | -2.92% |
| Operating Income | -24.31% | -7.40% | 2.25% | -13.96% | 6.53% |
| Income Before Tax | -21.09% | 0.03% | 2.73% | -12.60% | 6.50% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -21.09% | 0.03% | 2.73% | -12.60% | 6.50% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.09% | 0.03% | 2.73% | -12.60% | 6.50% |
| EBIT | -24.31% | -7.40% | 2.25% | -13.96% | 6.53% |
| EBITDA | -24.89% | -7.16% | 2.86% | -13.35% | 7.95% |
| EPS Basic | 63.29% | 60.13% | 53.43% | 28.67% | 16.31% |
| Normalized Basic EPS | 63.29% | 60.13% | 53.43% | 28.68% | 16.31% |
| EPS Diluted | 63.29% | 60.13% | 53.43% | 28.67% | 16.42% |
| Normalized Diluted EPS | 63.29% | 60.13% | 53.43% | 28.68% | 16.31% |
| Average Basic Shares Outstanding | 444.74% | 243.83% | 159.36% | 57.21% | 20.28% |
| Average Diluted Shares Outstanding | 444.74% | 243.83% | 159.36% | 57.21% | 20.28% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |